Few Patients With Firearm Injuries Receive Violence Intervention Program Services

Follow Drugslib on

By Lori Solomon HealthDay Reporter

Medically reviewed by Drugs.com

via HealthDay

TUESDAY, April 14, 2026 -- Nearly two-thirds of patients with firearm injuries are treated at trauma centers with violence intervention programs (VIPs), but only about one in five receive these services, according to a study published online April 7 in Journal of the American College of Surgeons.

Sara Larosiliere, from Quinnipiac University in Hamden, Connecticut, and colleagues compared patient populations between facilities that offer VIP services and those that do not. The analysis included 15,455 patients being treated for firearm violence.

The researchers found that 64.3 percent of patients were treated at VIP facilities. Patients at non-VIP facilities were older (mean age, 30.3 versus 29.8 years) and more often Black (64.3 versus 60.7 percent). Within VIP facilities, only 18.5 percent of patients received VIP services. These patients were younger (mean age, 27.84 versus 30.25 years), more often Black (72.8 versus 58.0 percent), and more often using Medicaid (55.2 versus 45.4 percent). The strongest predictor of VIP service use was assault-related injury (odds ratio, 3.00).

"Violence intervention programs are reaching the patients they are designed to serve, but not at a consistent level," Larosiliere said in a statement. "Improving access and integration of these programs could have a meaningful impact on recovery and outcomes after injury."

Abstract/Full Text

Disclaimer: Statistical data in medical articles provide general trends and do not pertain to individuals. Individual factors can vary greatly. Always seek personalized medical advice for individual healthcare decisions.

Source: HealthDay

Posted : 2026-04-15 02:08

Read more

Disclaimer

Every effort has been made to ensure that the information provided by Drugslib.com is accurate, up-to-date, and complete, but no guarantee is made to that effect. Drug information contained herein may be time sensitive. Drugslib.com information has been compiled for use by healthcare practitioners and consumers in the United States and therefore Drugslib.com does not warrant that uses outside of the United States are appropriate, unless specifically indicated otherwise. Drugslib.com's drug information does not endorse drugs, diagnose patients or recommend therapy. Drugslib.com's drug information is an informational resource designed to assist licensed healthcare practitioners in caring for their patients and/or to serve consumers viewing this service as a supplement to, and not a substitute for, the expertise, skill, knowledge and judgment of healthcare practitioners.

The absence of a warning for a given drug or drug combination in no way should be construed to indicate that the drug or drug combination is safe, effective or appropriate for any given patient. Drugslib.com does not assume any responsibility for any aspect of healthcare administered with the aid of information Drugslib.com provides. The information contained herein is not intended to cover all possible uses, directions, precautions, warnings, drug interactions, allergic reactions, or adverse effects. If you have questions about the drugs you are taking, check with your doctor, nurse or pharmacist.

Popular Keywords